Windstone Medical Packaging, Inc. recalls AMS Convenience Kit: DSAEK Pack - RX
Reason for recall
The convenience kits contain .0.9% Sodium Chloride Injection, USP products in Single Dose freeflex bags, which may contain blue Break-off-Parts (BOPs) that have detached from the infusion port during manipulation.
Affected product
Check your device
Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.
AMS Convenience Kit: DSAEK Pack - RX, Part Number AMS12394B
Lot / code information
- UDI
- B098AMS12394B0
- Lot #
241907, 241223, 241034, 240904, 240705, 240633 — +77 moreShow all
241907, 241223, 241034, 240904, 240705, 240633, 240269, 238361, 238197, 238146, 238085, 238084, 238041, 237957, 237901, 237843, 237663, 237444, 237443, 236863, 236740, 236250, 236249, 236111, 235602, 235601, 235442, 235026, 235025, 235024, 235023, 234889, 234839, 234458, 233931, 233930, 233762, 233328, 233224, 231945, 231124, 231123, 231122, 231081, 231080, 230970, 230969, 230968, 230697, 230696, 230695, 230694, 230098, 229977, 229825, 229824, 229656, 229655, 229565, 229390, 229238, 229141, 229140, 228793, 228718, 228572, 228263, 227828, 227540, 227112, 226969, 226897, 226841, 226714, 226572, 226382, 225455, 225276, 225275, 223916, 223915, 223914, 223913
What the firm is doing
An URGENT: MEDICAL DEVICE RECALL notification letter dated 7/29/26 was sent to customers. AMS requests that you undertake the following activities: 1. Immediately check your inventory for the recalled products listed above and place them under quarantine. 2. Due to the manufacturing process any finished sterilized packs remaining in inventory, or at your facility will require over labeling for all products affected by this recall. Packs will be labeled with a sticker attached to each pack. This sticker will read: RECALL NOTICE BD announced the recall of 70084 PHARMACY NACL .9% 100ML BAG contained in this kit after it was sealed and sterilized. All other components in the kit are not affected by this recall. "At the time the kit is opened for use any BD PHARMACY NACL .9% 100ML BAG should be identified and set aside. "The recalled BD PHARMACY NACL .9% 100ML BAG should be rendered unusable to protect against inadvertent use and disposed of pursuant to the medical waste policies in effect at your institution. 3.Complete the attached Recall Reply Form listing all inventory of affected product by lot number and quantity. 4.If you have further distributed this product, please identify your distribution partners, and notify them at once of the product recall. Your notification to your customers should include a copy of this notification letter. 5.Please complete the Recall Reply Form within 5 business days and return via email to fieldcorrectiveaction@alignedmedical.com even if you have no affected product on hand. 6.Indicate on the Recall Reply Form if replacement PHARMACY NACL .9% 100ML BAG are needed. Please complete the attached AMS Recall Reply Form and return it to Aligned Medical Solutions at the Fax number provided on the form. If you do not have the affected product, you must complete and return the AMS Recall Reply Form. Replacement BD Fresenius Kabi Freeflex IV Container contained within the kit will be issued upon request and completion of the attached Recal
DistributionShow detailsHide
US Nationwide distribution in the states of CA, GA, WA.
Use of the product may cause temporary or medically reversible adverse health consequences.
Sources & references
- FDA enforcement recordOfficial FDA database entry for Z-3138-2026
- FDA device classification · KDDOfficial FDA classification for this device type
- CFR regulation · 21 CFR 878.4800The federal regulation governing this device
- FDA recall announcementSearch FDA.gov for the official press announcement
- Find Windstone Medical Packaging, Inc.Search for the manufacturer's official notice
- News coverageRecent reporting on this recall and manufacturer
- openFDA data recordThe raw JSON record this page is built from
Source: U.S. FDA openFDA device enforcement reports. This summary is informational and may lag or differ from the official record. Always verify against the FDA before acting.
Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.
More Class II recalls
Nipro Renal Soultions USA, Corporation recalls Citric Complete Liquid Citric Acid Concentrate REF: LC+200-D
Hemodialysis concentrates contain high endotoxin levels
- Dialysate Concentrate For Hemodialysis (Liquid Or Powder)
- Process control
Nipro Renal Soultions USA, Corporation recalls Citric Complete Dry Citric Acid Concentrate REF: DCA+200-25 & DCA+203-25
Hemodialysis concentrates contain high endotoxin levels
- Dialysate Concentrate For Hemodialysis (Liquid Or Powder)
- Process control
Nipro Renal Soultions USA, Corporation recalls MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X
Hemodialysis concentrates contain high endotoxin levels
- Dialysate Concentrate For Hemodialysis (Liquid Or Powder)
- Process control
